Utah Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Utah Medical Products
UTMD Stock  USD 57.81  0.12  0.21%   
Utah Medical financial statements provide useful quarterly and yearly information to potential Utah Medical Products investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Utah Medical financial statements helps investors assess Utah Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Utah Medical's valuation are summarized below:
Gross Profit
24.1 M
Profit Margin
0.3392
Market Capitalization
193.2 M
Enterprise Value Revenue
2.6423
Revenue
40.9 M
There are over one hundred nineteen available fundamental trend indicators for Utah Medical Products, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Utah Medical's current performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 289.5 M. The current year's Enterprise Value is expected to grow to about 202 M

Utah Medical Total Revenue

36.6 Million

Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.7 M, Interest Expense of 669.3 K or Total Revenue of 36.6 M, as well as many indicators such as Price To Sales Ratio of 3.45, Dividend Yield of 0.0243 or PTB Ratio of 4.36. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
  
Check out the analysis of Utah Medical Correlation against competitors.

Utah Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets163.6 M155.8 M99.2 M
Slightly volatile
Short and Long Term Debt Total322.3 K339.2 K3.5 M
Slightly volatile
Other Current Liabilities2.6 M4.2 M2.5 M
Slightly volatile
Total Current Liabilities4.6 M5.4 M5.3 M
Slightly volatile
Total Stockholder Equity154.9 M147.6 M86.5 M
Slightly volatile
Property Plant And Equipment Net9.6 M12.1 M9.5 M
Slightly volatile
Cash112.1 M106.8 M45.9 M
Slightly volatile
Non Current Assets Total27.1 M33.6 M41.8 M
Pretty Stable
Cash And Short Term Investments112.1 M106.8 M45.9 M
Slightly volatile
Net Receivables4.5 M3.8 M4.1 M
Slightly volatile
Common Stock Shares Outstanding5 M3.3 M4.2 M
Slightly volatile
Liabilities And Stockholders Equity163.6 M155.8 M99.2 M
Slightly volatile
Non Current Liabilities Total5.2 M2.8 M7.4 M
Slightly volatile
Inventory11.6 M11 M6.3 M
Slightly volatile
Other Current Assets411.3 K432.9 K539.1 K
Slightly volatile
Other Stockholder Equity507.9 K534.6 K1.4 M
Slightly volatile
Total Liabilities9.7 M8.2 M12.7 M
Slightly volatile
Property Plant And Equipment Gross41.4 M39.4 M17.5 M
Slightly volatile
Total Current Assets128.3 M122.2 M56.8 M
Slightly volatile
Intangible Assets5.4 M5.7 M25.4 M
Slightly volatile
Accounts Payable1.3 M884.4 K1.6 M
Slightly volatile
Short Term Debt51.3 K54 K1.2 M
Slightly volatile
Common Stock Total Equity32 K32.4 K37.9 K
Slightly volatile
Common Stock31.9 K32.4 K37.9 K
Slightly volatile
Property Plant Equipment10.1 M11.8 M9.9 M
Slightly volatile
Good Will13 M15.7 M13.9 M
Pretty Stable
Other Liabilities4.9 M3.8 M4.3 M
Pretty Stable
Retained Earnings Total Equity93.3 M144.9 M89 M
Slightly volatile
Long Term Debt Total8.1 M4.6 M6.9 M
Slightly volatile
Capital Surpluse214.6 K225.9 K988.3 K
Slightly volatile
Non Current Liabilities Other3.5 M3.6 M3.6 M
Slightly volatile
Short and Long Term Debt3.1 M3.5 M3.8 M
Slightly volatile
Net Invested Capital113.3 M147.6 M95.5 M
Slightly volatile
Net Working Capital73 M116.8 M60.1 M
Slightly volatile
Capital Stock29.2 K32.4 K36 K
Slightly volatile
Capital Lease Obligations268.5 K265.5 K349.7 K
Slightly volatile

Utah Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization7.7 M7.3 M4.7 M
Slightly volatile
Total Revenue36.6 M57.8 M41.7 M
Slightly volatile
Gross Profit20.6 M34.5 M25.2 M
Slightly volatile
Other Operating Expenses23.9 M38.5 M25.5 M
Slightly volatile
Operating Income11.7 M19.3 M14.1 M
Slightly volatile
Cost Of Revenue16 M23.2 M16.4 M
Slightly volatile
Total Operating Expenses8.3 M15.3 M9.8 M
Slightly volatile
Income Before Tax13 M23.1 M15.9 M
Slightly volatile
Net Income9.6 M19.1 M12.1 M
Slightly volatile
Income Tax Expense3.8 M4 M3.8 M
Pretty Stable
Research Development472.8 K504 K559.7 K
Slightly volatile
Selling General Administrative6.9 M12.7 M7.8 M
Slightly volatile
Net Income Applicable To Common Shares11.8 M18.9 M13.9 M
Pretty Stable
Selling And Marketing Expenses1.5 M1.5 M1.9 M
Slightly volatile
Net Income From Continuing Ops16.8 M19.4 M15.6 M
Slightly volatile
Tax Provision3.4 M3.4 M3.9 M
Very volatile
Interest Income306.7 K292.1 K156.7 K
Slightly volatile
Reconciled Depreciation6.5 M8.1 M4.7 M
Slightly volatile

Utah Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation271.7 K258.8 K157.3 K
Pretty Stable
Begin Period Cash Flow90.6 M86.3 M37.6 M
Slightly volatile
Depreciation7.7 M7.3 M4.7 M
Slightly volatile
Capital Expenditures698.1 K734.9 K2.1 M
Very volatile
Total Cash From Operating Activities26.9 M25.6 M17.1 M
Slightly volatile
Net Income10.1 M19.1 M12.3 M
Slightly volatile
Dividends Paid4.2 M4.9 M4.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.455.495.6437
Slightly volatile
Dividend Yield0.02430.01610.0172
Pretty Stable
PTB Ratio4.362.753.2271
Slightly volatile
Days Sales Outstanding50.5727.938.6354
Slightly volatile
Book Value Per Share33.3431.7522.3008
Slightly volatile
Operating Cash Flow Per Share5.795.514.39
Slightly volatile
Stock Based Compensation To Revenue0.00220.0040.0027
Slightly volatile
Capex To Depreciation0.110.120.7339
Slightly volatile
PB Ratio4.362.753.2271
Slightly volatile
EV To Sales3.223.834.897
Slightly volatile
ROIC0.20.120.1255
Very volatile
Inventory Turnover2.32.423.0057
Slightly volatile
Net Income Per Share4.324.123.3126
Slightly volatile
Days Of Inventory On Hand84.57156123
Slightly volatile
Payables Turnover15.7423.6218.7551
Slightly volatile
Sales General And Administrative To Revenue0.130.20.1676
Slightly volatile
Research And Ddevelopement To Revenue0.01870.01280.0137
Slightly volatile
Capex To Revenue0.01390.01460.0477
Very volatile
Cash Per Share24.1322.9811.6685
Slightly volatile
POCF Ratio16.6915.8116.144
Slightly volatile
Interest Coverage291277182
Slightly volatile
Payout Ratio0.30.230.3246
Very volatile
Capex To Operating Cash Flow0.03130.0330.1304
Very volatile
Days Payables Outstanding23.515.9920.3946
Slightly volatile
Income Quality1.021.211.345
Pretty Stable
ROE0.260.150.1605
Very volatile
EV To Operating Cash Flow15.8711.0314.2727
Very volatile
PE Ratio14.2316.5720.8406
Very volatile
Return On Tangible Assets0.280.160.2268
Slightly volatile
Earnings Yield0.07240.06250.0519
Very volatile
Intangibles To Total Assets0.180.120.3528
Slightly volatile
Current Ratio21.3220.3111.7105
Slightly volatile
Receivables Turnover14.2213.5410.5045
Slightly volatile
Graham Number56.9454.2340.5657
Slightly volatile
Shareholders Equity Per Share33.3431.7522.3008
Slightly volatile
Debt To Equity0.00250.00260.0872
Slightly volatile
Capex Per Share0.290.160.5677
Pretty Stable
Revenue Per Share13.0512.4311.1764
Slightly volatile
Interest Debt Per Share0.06940.0730.929
Slightly volatile
Debt To Assets0.00240.00250.0549
Slightly volatile
Enterprise Value Over EBITDA8.217.7710.4554
Very volatile
Short Term Coverage Ratios4.324.543.9399
Pretty Stable
Price Earnings Ratio14.2316.5720.8406
Very volatile
Operating Cycle120178158
Slightly volatile
Price Book Value Ratio4.362.753.2271
Slightly volatile
Days Of Payables Outstanding23.515.9920.3946
Slightly volatile
Dividend Payout Ratio0.30.230.3246
Very volatile
Price To Operating Cash Flows Ratio16.6915.8116.144
Slightly volatile
Pretax Profit Margin0.270.360.358
Slightly volatile
Ebt Per Ebit0.91.081.1596
Slightly volatile
Operating Profit Margin0.250.30.3207
Very volatile
Effective Tax Rate0.340.20.2617
Slightly volatile
Company Equity Multiplier1.411.211.2576
Slightly volatile
Long Term Debt To Capitalization0.01620.01710.0595
Slightly volatile
Total Debt To Capitalization0.00250.00260.0653
Slightly volatile
Return On Capital Employed0.140.150.1651
Slightly volatile
Debt Equity Ratio0.00250.00260.0872
Slightly volatile
Ebit Per Revenue0.250.30.3207
Very volatile
Quick Ratio19.418.4810.3288
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.755.213.8514
Very volatile
Net Income Per E B T0.580.750.7301
Pretty Stable
Cash Ratio18.6317.759.4424
Slightly volatile
Cash Conversion Cycle104165140
Slightly volatile
Operating Cash Flow Sales Ratio0.260.40.3655
Slightly volatile
Days Of Inventory Outstanding84.57156123
Slightly volatile
Days Of Sales Outstanding50.5727.938.6354
Slightly volatile
Cash Flow Coverage Ratios71.3767.9839.9577
Slightly volatile
Price To Book Ratio4.362.753.2271
Slightly volatile
Fixed Asset Turnover4.45.474.4541
Pretty Stable
Capital Expenditure Coverage Ratio15.9231.3827.4475
Pretty Stable
Price Cash Flow Ratio16.6915.8116.144
Slightly volatile
Enterprise Value Multiple8.217.7710.4554
Very volatile
Debt Ratio0.00240.00250.0549
Slightly volatile
Cash Flow To Debt Ratio71.3767.9839.9577
Slightly volatile
Price Sales Ratio3.455.495.6437
Slightly volatile
Return On Assets0.210.140.1322
Slightly volatile
Asset Turnover0.410.430.4898
Slightly volatile
Net Profit Margin0.20.30.2699
Slightly volatile
Gross Profit Margin0.440.540.5813
Very volatile
Price Fair Value4.362.753.2271
Slightly volatile
Return On Equity0.260.150.1605
Very volatile

Utah Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap289.5 M275.7 M247.8 M
Slightly volatile
Enterprise Value202 M192.4 M188.5 M
Slightly volatile

Utah Fundamental Market Drivers

Cash And Short Term Investments92.9 M

Utah Upcoming Events

23rd of April 2024
Upcoming Quarterly Report
View
31st of March 2024
Next Fiscal Quarter End
View

About Utah Medical Financial Statements

Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue294.3 K232.6 K
Total Revenue57.8 M36.6 M
Cost Of Revenue23.2 M16 M
Sales General And Administrative To Revenue 0.20  0.13 
Research And Ddevelopement To Revenue 0.01  0.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 12.43  13.05 
Ebit Per Revenue 0.30  0.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
How To Invest In Utah
Details
Is Utah Stock a good investment?
Details
What is Utah Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Utah Medical Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Dividend Share
1.205
Earnings Share
3.96
Revenue Per Share
11.677
Quarterly Revenue Growth
(0.26)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY